Evidence map›Paper›PMID 30271037›Full record

ArticleJournal of neurosciences in rural practice

The Effect of Statins in Epilepsy: A Systematic Review.

Loraine De Jesús Quintana-Pájaro, Yancarlos Ramos-Villegas, Eileen Cortecero-Sabalza, Andrei F Joaquim, Amit Agrawal, Alexis Rafael Narvaez-Rojas, Luis Rafael Moscote-Salazar

Open access · goldAbstract read
In one paragraph

Article in Journal of neurosciences in rural practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Loraine De Jesús Quintana-PájaroDepartment of Medicine, University of Cartagena, Cartagena de Indias, Colombia.
Yancarlos Ramos-VillegasDepartment of Medicine, University of Cartagena, Cartagena de Indias, Colombia.
Eileen Cortecero-SabalzaDepartment of Medicine, University of Cartagena, Cartagena de Indias, Colombia.
Andrei F JoaquimDepartment of Neurology, Division of Neurosurgery, State University of Campinas, Campinas, Sao Paulo, Brazil.
Amit AgrawalDepartment of Neurosurgery, MM Institute of Medical Sciences and Research, Maharishi Markandeshwar University, Ambala, Haryana, India.
Alexis Rafael Narvaez-RojasDepartment of Medicine, National Autonomous University of Nicaragua, Managua, Nicaragua.
Luis Rafael Moscote-SalazarDepartment of Medicine, University of Cartagena, Cartagena de Indias, Colombia.
Institute of Medical Sciences · INNational Autonomous University of Nicaragua · NIUniversidade Estadual de Campinas (UNICAMP) · BRUniversity of Cartagena · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesStatins are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, used for the management of hypercholesterolemia and related atherosclerotic diseases. Several studies have indicated the neuroprotective effects of statins on several neuropathological conditions. However, the role of these medications in epilepsy is still unclear. The purpose is to evaluate and summarize the level of evidence on the efficacy of statins in neuronal hyperexcitability and the neuroinflammatory processes of epilepsy.

methodsA systematic review was performed. Eligibility Criteria: This review involved studies conducted in humans and nonhuman experimental models, covering the use of an inhibitor of HMG-CoA reductase, alone or accompanied by another medication, in epilepsy. Information Sources: A systematic literature search was performed in PubMed, Embase, Ebsco Host, Scopus, Science Direct, Medline, and LILACS. Risk of Bias: It was evaluated with the Newcastle-Ottawa Scale and the experimental studies were evaluated using the GRADE tool.

resultsTwenty articles of the 183 evaluated were included. Sixteen studies were conducted in animal models and four studies in humans. Most studies in mice reported a reduction in epileptiform activity and reduction in systemic inflammation with the treatment of statins, potentially influencing epilepsy control. Few studies in humans were performed in the geriatric population with variable results (neuroinflammation, seizure prevention, cell death, prevention of kindling, increase in convulsive threshold, increase in latency, decrease in frequency of crisis, and reduction in mortality) related to reduction in the rate of hospitalizations, mortality, and prevention of epilepsy. Studies in mice found a decrease in interleukin-1β (IL-1β), IL-6, and tumor necrosis factor alpha and an increase in IL-10 and endothelial nitric oxide synthase.

conclusionsThe possible antiepileptic mechanism of statins may be related to the reduction in neuroinflammation mediated by a decrease in pro-inflammatory cytokines and action in the nitrergic system. Further studies evaluating the impact of statins on seizure control are necessary.

Indexed as

Brainepilepsyseizurestatins

Identifiers

PMID30271037
PMCPMC6126295
OpenAlexW2889400904

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.